Replies to post #145032 on Biotech Values

[mcbio]

Living in the same town as BINV ,

First, show-off and I'm jealous. ; )

I can confirm that the market cap is only 421M SEK which today is roughly $61M. They have approx. $30M in cash.

Do you have any confidence in either the Phase 2a readout for BI-204 or the Phase 1 readout for BI-505 this quarter? If either of those readouts is positive, I could envision the stock being pretty cheap here. And I also like that BINV has some cash. Of course, if both trials disappoint, I'm sure the stock will be further hit and not sure what is left behind these two drugs that could legitimately bring interest back down the road.